Biosimilars Market Access in the EU and USA
05.02.2020 16:39
This biosimilars course addresses the available options for market access in the US and EU, including negotiating with the originator.
Termindetails
Wann
19.05.2020
von 09:00 bis 17:00
von 09:00 bis 17:00
Wo
Berlin
Kontakttelefon
+49 6221 500-680
Teilnehmer
This course is intended for managing directors, market access managers, legal and IP departments involved in placing a biosimilar product on EU or US markets.
Seminar target:
This course will prepare you for a biosimilar market entry in the EU or USA. It will give you a deeper understanding of the available options for negotiating, licencing and challenging patents, and how to promote your market entry with a distinctive pre-launch communication and appropriate tenders.
Topics:
- Licencing or challenging patents in the USA
- Negotiating settlement agreements
- First to market requirements for the main EU markets
- Negotiating exclusivity rights for the EU markets
